Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali (R)) Versus Etanercept (Enbrel (R)) - Findings from a Nurse Survey in Europe (vol 3, pg 77, 2016)

被引：0

|

作者：

Thakur, Kunal ^{[1
]}

Biberger, Anna ^{[2
]}

Handrich, Alexandra ^{[1
]}

Rezk, Mourad Farouk ^{[1
]}

机构：

[1] Biogen Int GmbH, Zug, Switzerland

[2] Kantar Hlth GmbH, Munich, Germany

来源：

RHEUMATOLOGY AND THERAPY | 2016年 / 3卷 / 02期

关键词：

D O I：

10.1007/s40744-016-0045-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：365 / 365

页数：1

相关论文

共 3 条

[1] Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Thakur K.
Biberger A.
Handrich A.
Rezk M.F.
Rheumatology and Therapy, 2016, 3 (1) : 77 - 89
[2] Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Kunal Thakur
Anna Biberger
Alexandra Handrich
Mourad Farouk Rezk
Rheumatology and Therapy, 2016, 3 (2) : 365 - 365
[3] Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe
Thakur K.
Biberger A.
Handrich A.
Rezk M.F.
Rheumatology and Therapy, 2016, 3 (2) : 245 - 256